Spinal Stenosis
Conditions
Brief summary
This study is to assess the clinical efficacy of epidural injections with Tumor Necrosis Factor-Alpha(TNF-α) Inhibitor in patients with chronic radicular pain caused by lumbar spinal stenosis.
Detailed description
This study is to assess the clinical efficacy of epidural injections with Tumor Necrosis Factor-Alpha(TNF-α) Inhibitor in patients with chronic radicular pain caused by lumbar spinal stenosis.Ninety patients were diagnosed with lumbar spinal stenosis and were randomly assigned to 3 groups, for each group 30 cases. Patients in Group A received epidural injection of spinal nerve with 2.0 ml of lidocaine and 10 mg of Tumor Necrosis Factor-Alpha Inhibitor (etanercept) onto the affected spinal nerve, Group B patients received epidural injection with lidocaine 2ml mixed with 2ml of steroid(Diprospan), and group C patients received epidural injections with 4.0 ml of lidocaine only. All the 3 groups were evaluated by VAS and ODI, and received 6 months' follow-up.
Interventions
Epidural administration with TNF-α inhibitor
Sponsors
Study design
Eligibility
Inclusion criteria
* Diagnosis of spinal stenosis with radicular pain at least 5 scores of VAS(ranging from 0 to 10). * Failed to improve symptom significantly through conservative treatment, including physiotherapy, chiropractic therapy, exercise, medication and bed rest.
Exclusion criteria
* lumbar surgery history, * spinal stenosis without radicular pain, * uncontrollable or unstable use of opioids, * uncontrolled mental illness, * pregnant or lactating women, * patients with a history of adverse reactions or possible adverse reactions to local anesthetics, etanercept or Steroids.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| visual analog scale | 6 months | visual analog scale(0-10 scores) is for pain, 0 represent no pain, 10 score represent the severe pain. |
| Oswestry Disability Index | 6 months | Oswestry Disability Index is for movement function, Questionnaire examines |